“Father of Surgical Robotics” Dr. Fred Moll Joins ForSight Robotics Board of Directors

Industry Veteran Joins Expanding Team, Bringing Category-Defining Robotics Expertise to Further Company’s Mission of Transforming Surgical Eye Care

ForSight Robotics, the pioneer in ophthalmic robotic surgery, announced today that Dr. Fred Moll, the founder of Intuitive Surgical, has joined its Board of Directors. Intuitive Surgical is the company behind the da Vinci surgical system, the first robotic surgical platform commercially available in the U.S. to be cleared by the FDA for use in general laparoscopic surgery. His appointment to the Board of Directors marks his first advisor role for an ophthalmology-focused surgical robotics company.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250213921593/en/

Dr. Fred Moll (Photo: Dr. Fred Moll)

“Dr. Moll’s incredible legacy of pioneering the surgical robotics category perfectly aligns with our mission to transform the future of eye surgery,” said Dr. Joseph Nathan, ForSight Robotics’ co-founder, president, and Chief Medical Officer. “As we look to bring the ORYOM™ Platform, the world's first platform for fully robotic cataract surgery, to market, Dr. Moll’s unparalleled expertise will be instrumental in accelerating our growth and shaping ophthalmic innovation.”

A distinguished and prolific medical device entrepreneur, Dr. Moll brings decades of expertise to the ForSight Board. He founded Intuitive Surgical in the 1990s, pioneering robotic-assisted surgery and transforming minimally invasive procedures across dozens of specialties with its da Vinci robotic system. He then founded Auris Health, which was acquired by Johnson & Johnson in 2019. Most recently, he served as Chief Development Officer for J&J Medical Devices between 2019 and 2023. He has served on ForSight’s Strategic Advisory Board since the company’s founding in 2020 and is a current investor in ForSight Robotics.

“Throughout my career, I have worked with medical robotics companies to improve healthcare access and outcomes for patients worldwide,” said Dr. Moll. “ForSight Robotics is advancing surgical robotics in eye care, helping to avoid preventable blindness and address the global shortage of ophthalmic surgeons. Having supported the company since its inception, I’m confident in its team, tools, and potential to reshape the industry. I’m proud to continue serving as a strategic advisor during this period of significant growth.”

Dr. Moll’s appointment comes alongside the recent hiring of Yonatan Ushpizin as vice president of research and development and Ilanit Edri as vice president of people, reflecting ForSight’s strategic effort to expand its leadership team. Ushpizin brings nearly 20 years of experience leading multidisciplinary product development from concept to commercialization at companies like Medtronic, Mazor Robotics, and Meytar R&D. Most recently, he served as Director of Robotics Research and Technology at Medtronic, where he played a key role in advancing robotics innovation. At ForSight, he will spearhead the next phase of the ORYOM™ Platform’s evolution as the company scales.

Edri brings over 25 years of experience in HR leadership roles within leading global organizations. Throughout her career, Ilanit has held key positions, such as Vice President of Human Resources at Elbit Systems (ISTAR Division) and VP of HR at The Open University of Israel. Additionally, she served as Head of HR for Teva Pharmaceuticals’ Global Generic R&D, for Tnuva Dairy, and for Medtronic Ventor. At ForSight, Edri will drive the company’s growth while cultivating a high-performance culture and aligning talent strategies with business objectives. Ushpizin and Edri are the first to hold these positions, underscoring a pivotal step in ForSight’s advancement and long-term vision.

“With the addition of Yonatan and Ilanit to our leadership team and the unparalleled guidance of Dr. Moll, ForSight is positioned to revolutionize ophthalmic surgery,” said Dr. Nathan. “Together, we are building a future where cutting-edge robotic surgery eradicates preventable blindness and sets new standards in surgical excellence; we are thrilled to lead the charge in transforming eye care worldwide.”

About ForSight Robotics:

ForSight Robotics is a surgical robotics company pioneering world-class technology to democratize quality surgical eye care. The Israel-based company is developing the ORYOM^TM Platform (“daylight” in Hebrew), the world’s first robotic surgery platform for cataracts and eye diseases, which will utilize AI-based algorithms, computer vision, and miniaturized-mechanics. Backed by globally-recognized VCs and industry leaders, ForSight is redefining ophthalmic surgery and bringing hope to millions of patients worldwide. Visit forsightrobotics.com and follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250213921593/en/

“Together, we are building a future where cutting-edge robotic surgery eradicates preventable blindness and sets new standards in surgical excellence; we are thrilled to lead the charge in transforming eye care worldwide,” said Dr. Joseph Nathan.